Evidence map›Paper›PMID 40004163›Full record

ArticleInternational journal of molecular sciences2025

Leukemia-Derived Dendritic Cells Induce Anti-Leukemic Effects Ex Vivo in AML Independently of Patients' Clinical and Biological Features.

Lara Kristina Klauer, Hazal Aslan Rejeski, Selda Ugur, Elias Rackl, Joudi Abdulmajid, Zuzanna Fischer, Elena Pepeldjiyska, Annalena Frischhut, Nicolas Schmieder, Antje Völker and 5 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lara Kristina KlauerDepartment of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.
Hazal Aslan RejeskiDepartment of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.ORCID 0009-0006-1547-5983
Selda UgurDepartment of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.
Elias RacklDepartment of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.ORCID 0009-0003-2940-5212
Joudi AbdulmajidDepartment of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.
Zuzanna FischerDepartment of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.
Elena PepeldjiyskaDepartment of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.
Annalena FrischhutDepartment of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.
Nicolas SchmiederDepartment of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.
Antje VölkerDepartment of Statistics, Ludwig-Maximilian-University Munich, 80539 Munich, Germany.
Andreas RankBavarian Cancer Research Center (BZKF), 80539 Munich, Germany.ORCID 0000-0002-5636-0043
Christoph SchmidBavarian Cancer Research Center (BZKF), 80539 Munich, Germany.
Jörg SchmohlDepartment of Haematology and Oncology, Diakonie-Klinikum, 70176 Stuttgart, Germany.
Daniel Christoph AmbergerDepartment of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.ORCID 0000-0002-5331-0884
Helga Maria SchmetzerDepartment of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New therapies are highly needed to stabilize remission in patients with acute myeloid leukemia (AML). This study investigates the value of dendritic cells derived from leukemic blasts (DC

Indexed as

Dendritic CellsLeukemia, Myeloid, AcuteAdultAgedFemaleGranulocyte-Macrophage Colony-Stimulating FactorHumansLymphocyte Culture Test, MixedMaleMiddle AgedPrognosisT-LymphocytesGranulocyte-Macrophage Colony-Stimulating FactorAMLanti-leukemic activityDC/DCleu-generating protocolsleukemia-derived dendritic cells

Identifiers

PMID40004163
PMCPMC11855365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.